<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> is the principal cause of <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and induces progression of severe <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in these patients </plain></SENT>
<SENT sid="1" pm="."><plain>Adiponectin, the adipose-specific proteins, is known to correlate negatively with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in patients with <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to evaluate the potential of using serum adiponectin levels as a marker of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in various states of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, we attempted to establish a modified index of the homeostasis model assessment index (HOMA-IR), calculated from the product of serum insulin and plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels divided by serum adiponectin levels (HOMA-AD) </plain></SENT>
<SENT sid="4" pm="."><plain>We recruited 117 Japanese subjects with various degrees of <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance and determined serum adiponectin levels and insulin sensitivity (M-value) by using the euglycemic hyperinsulinemic clamp technique </plain></SENT>
<SENT sid="5" pm="."><plain>M-value, the gold standard index of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, correlates significantly and independently with fasting insulin (r=-0.313, P&lt;0.001), <z:chebi fb="105" ids="17234">glucose</z:chebi> (r=-0.319, P&lt;0.001), and adiponectin (r=0.241, P&lt;0.002) levels </plain></SENT>
<SENT sid="6" pm="."><plain>M-values were more significantly correlated with HOMA-AD (r=-0.643, P&lt;0.001) than HOMA-IR values (r=-0.591, P&lt;0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>In subjects with moderate <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> levels&gt;8.0mmol/L, n=30), HOMA-AD showed a more significant correlation with the M-value than HOMA-IR (r=-0.535, P=0.005 versus r=-0.461, P=0.010) </plain></SENT>
<SENT sid="8" pm="."><plain>We would therefore like to propose a novel index, HOMA-AD, as a simple and adequate index for determining <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> even in diabetic patients with overt <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
</text></document>